| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/15/2010 | CN101069742B Pancreatic kininogenase tablet and preparing method |
| 09/15/2010 | CN101019848B Application of ferricitras in preparation of medicine to prevent and treat angiosteosis |
| 09/14/2010 | US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest |
| 09/14/2010 | US7795450 aministering N-(2,4-di-n-amylpentanoic acid amide)-tryptophanamide, for the treatment of diseases associated with the decreased binding of magnesium to the plasma membranes of their cells, such as hypertension, diabetes, non-insulin depepndent diabetes, pre-eclampsia and eclampsia |
| 09/14/2010 | US7795302 use of topical formulation for treating rosacea containing a combination of an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 09/14/2010 | US7795289 Use of acylaminothiazole derivatives as therapeutic agents |
| 09/14/2010 | US7795281 (R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester; calcium antagonistic action, antihypertensive action, vascular dilatory action, cardiac protective action, anti-arteriosclerotic action, diuretic action |
| 09/14/2010 | US7795278 Substituted tetrahydro-2H-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 09/14/2010 | US7795269 3-Ethyl-1-propyl-8-{1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl}-1,3,7-trihydropurine-2,6-dione; antiasthmatic and antidiarrhea agents |
| 09/14/2010 | US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia |
| 09/14/2010 | US7795264 Tyrosine kinase with immunoglobulin and epidermal growth factor homology domain signaling inhibitors; dysregulated vascular growth disorders |
| 09/14/2010 | US7795229 beta-lactam compounds having a C-glycoside in the molecule, in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor selected from atorvastatin and rosuvastatin; synergistic |
| 09/14/2010 | US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 09/14/2010 | US7795212 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors |
| 09/14/2010 | US7795018 expresses CD14, CD34, CD45, type I collagen, and HLA-DR; differentiates into osteoblasts, skeletal myoblasts or chondrocytes; obtained by culturing peripheral blood mononuclear cells (PBMCs) in vitro on fibronectin; noninvasive; will not cause rejection at the time of cell transplantation |
| 09/14/2010 | US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 09/14/2010 | US7794927 Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1 |
| 09/14/2010 | CA2479353C N-substituted benzothiophenesulfonamide derivative |
| 09/14/2010 | CA2454786C Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 09/14/2010 | CA2441501C Rho-kinase inhibitors |
| 09/14/2010 | CA2434834C 6-substituted pyrido-pyrimidines |
| 09/14/2010 | CA2415558C Acid addition salts of hydropyridine derivatives |
| 09/14/2010 | CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase |
| 09/14/2010 | CA2401757C Novel fatty acid analogues |
| 09/14/2010 | CA2388979C Treatment or prevention of hypotension and shock with use of an imidazole derivative |
| 09/14/2010 | CA2347913C Oral administration of adenosine analogs |
| 09/14/2010 | CA2322792C Polypeptides homologous to vegf and bmp1 |
| 09/10/2010 | WO2010102216A2 Enhancing coagulation or reducing fibrinolysis |
| 09/10/2010 | WO2010101949A1 8-substituted quinolines and related analogs as sirtuin modulators |
| 09/10/2010 | WO2010101237A1 Polypeptides and antibacterial or antiseptic use of same |
| 09/10/2010 | WO2010101164A1 Pyridine derivative |
| 09/10/2010 | WO2010100405A1 Triazine derivatives as kinase inhibitors |
| 09/10/2010 | WO2010100255A1 Pharmaceutical hypocholesterolemic compositions |
| 09/10/2010 | WO2010100248A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak) |
| 09/10/2010 | WO2010071358A3 Method of preparing ezetimibe and intermediates used therein |
| 09/10/2010 | WO2010059372A3 Tryptase enzyme inhibiting aminopyridines |
| 09/10/2010 | WO2010055419A3 A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosclerosis |
| 09/10/2010 | WO2010052448A3 Fused pyrazine derivatives as kinase inhibitors |
| 09/10/2010 | CA2754549A1 Enhancing coagulation or reducing fibrinolysis |
| 09/10/2010 | CA2754446A1 Pyridine derivative |
| 09/10/2010 | CA2754384A1 Pharmaceutical hypocholesterolemic compositions |
| 09/10/2010 | CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators |
| 09/10/2010 | CA2753991A1 Secreted ap2 and methods of inhibiting same |
| 09/10/2010 | CA2753637A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak) |
| 09/09/2010 | US20100229251 Methods and Compositions for Detecting and Treating End-Stage Cardiomyopathy Using Claudin-5 |
| 09/09/2010 | US20100227934 Therapeutic compounds and methods of use |
| 09/09/2010 | US20100227932 Patch |
| 09/09/2010 | US20100227922 storage stable drug as mouth spray containing glycerol trinitrate, a triglyceride, an alcohol( ethanol, propylene glycol), a buffer ( sodium lactate, sodium phosphate and sodium stearate), water, a medium-chain partial glyceride, and a flavoring agent; treatment of angina pectoris using pump spray |
| 09/09/2010 | US20100227914 RNA Antagonist Compounds for the Inhibition of Apo-B100 Expression |
| 09/09/2010 | US20100227903 Polymer Formulations of CETP Inhibitors |
| 09/09/2010 | US20100227901 Compounds for the treatment of metabolic disorders |
| 09/09/2010 | US20100227894 Benzamide factor viia inhibitors useful as anticoagulants |
| 09/09/2010 | US20100227882 Clopidogrel salt and polymorphic forms thereof |
| 09/09/2010 | US20100227873 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 09/09/2010 | US20100227869 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands |
| 09/09/2010 | US20100227865 Oligomer-Beta Blocker Conjugates |
| 09/09/2010 | US20100227859 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 09/09/2010 | US20100227858 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 09/09/2010 | US20100227857 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors |
| 09/09/2010 | US20100227855 Helix 12 directed non-steroidal antiandrogens |
| 09/09/2010 | US20100227853 Inhibitors of cyclic amp phosphodiesterases |
| 09/09/2010 | US20100227847 Non-Anilinic Derivatives Of Isothiazol-3(2H)-one 1,1-Dioxides As Liver X Receptor Modulators |
| 09/09/2010 | US20100227841 Patient populations and treatment methods |
| 09/09/2010 | US20100227828 New synergistic phytochemical composition for the treatment of obesity |
| 09/09/2010 | US20100227817 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide |
| 09/09/2010 | US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 09/09/2010 | US20100227354 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/09/2010 | US20100227002 Antioxidant compositions comprising extracts of myrtle and rosemary |
| 09/09/2010 | US20100226996 Compositions and methods of delivery of pharmacological agents |
| 09/09/2010 | US20100226986 Therapeutic Particles Suitable for Parenteral Administration and Methods of Making and Using Same |
| 09/09/2010 | US20100226977 Low viscosity phospholipid compositions |
| 09/09/2010 | US20100226970 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 09/09/2010 | US20100226953 Medical devices having a coating of biologic macromolecules |
| 09/09/2010 | US20100226929 Direct Oxidation of Calcium/Calmodulin Dependent Protein Kinase II and Associated Diagnostic and Therapeutic Methods |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226918 Pyrrole derivatives as p2y12 antagonists |
| 09/09/2010 | US20100226893 High Retention Cell Injectate |
| 09/09/2010 | US20100226858 Method of predicting a predisposition to qt prolongation |
| 09/09/2010 | DE102009011264A1 New ecdysone compounds useful for treating age-related diseases such as osteoporosis, osteoarthritis, incontinence, obesity, arteriosclerosis, hypertonus, metabolic syndrome, anemias, hyperandrogenemia, cellulite and menopausal hot flushes |
| 09/09/2010 | DE102009001283A1 Mineralocorticoid receptor antagonist, useful for reducing the myocardial infarction with reperfusion |
| 09/08/2010 | EP2226632A1 Method for screening of cell-protecting agent |
| 09/08/2010 | EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii |
| 09/08/2010 | EP2226318A2 Dye-Azide compounds for dual photherapy |
| 09/08/2010 | EP2226315A1 2-aminoquinazoline derivative |
| 09/08/2010 | EP2226085A1 Anti-angiogenic compositions and methods of use |
| 09/08/2010 | EP2226083A1 Drug delivery system |
| 09/08/2010 | EP2226079A2 Stem cell derived paracrine factor SFRP2 for use in reducing cell death |
| 09/08/2010 | EP2226036A1 Compositions and their use for enhancing vascular access |
| 09/08/2010 | EP2225253A1 Phosphonic acid derivates and their use as p2y12 receptor antagonists |
| 09/08/2010 | EP2225244A1 Imidazoý1,2-a¨pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/08/2010 | EP2225243A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazoýl,2- a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/08/2010 | EP2225240A2 Derivatives of 6-heterocyclic-imidazoýl,2-a¨pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/08/2010 | EP2225227A2 Compounds |
| 09/08/2010 | EP2225225A2 Angiotensin ii receptor antagonists |
| 09/08/2010 | EP2225223A2 Organic compounds |
| 09/08/2010 | EP2225214A1 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators |
| 09/08/2010 | EP2225210A1 Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
| 09/08/2010 | EP2225002A1 Rna interference for the treatment of heart failure |
| 09/08/2010 | EP2224937A2 Composition for preventing and treating metabolic diseases comprising the extract of lysimachiae foenum-graeci herba |
| 09/08/2010 | EP2224931A2 Beta glycolipids for the treatment of calcification related degenerative disorders |